Stable Coronary Artery Disease: Treatment.

Area of Science:

• Cardiology
• Internal Medicine

Background:

• Stable coronary artery disease (CAD) involves reversible myocardial ischemia due to supply/demand mismatch.
• It is characterized by plaque, history of myocardial infarction, or documented CAD.
• Patients are stable if asymptomatic or symptoms are managed with medication or revascularization.

Purpose of the Study:

• To outline current management strategies for stable coronary artery disease.
• To emphasize risk factor modification and guideline-directed medical therapy.
• To discuss the role of lifestyle changes, pharmacotherapy, and revascularization.

Main Methods:

• Review of established treatment guidelines and clinical evidence.
• Focus on risk factor management including tobacco cessation, exercise, and weight loss.
• Pharmacological management including statins, antiplatelet agents, and antianginal drugs.

Main Results:

• Risk factor optimization (diabetes, hyperlipidemia, hypertension) is crucial.
• Statins are recommended for all patients unless contraindicated.
• Aspirin is the primary antiplatelet agent; beta-blockers are first-line antianginals.

Conclusions:

• Comprehensive management of stable CAD requires a multi-faceted approach.
• Lifestyle modifications and aggressive risk factor control are paramount.
• Pharmacotherapy and revascularization are tailored to individual patient needs and symptom control.